| J9271 | Injection, pembrolizumab, 1 mg | 17,000 | $40 | $731K |
| J9299 | Injection, nivolumab, 1 mg | 27,120 | $20 | $650.9K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 860 | $90 | $78.4K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 560 | $90 | $53K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 630 | $60 | $36.5K |
| J0897 | Injection, denosumab, 1 mg | 1,320 | $20 | $23.8K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 150 | $130 | $19.7K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 420 | $50 | $19.5K |
| 99232 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making or… | 300 | $60 | $17.5K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 100 | $140 | $13.9K |